Kybella Injection, Solution
Product Images NDC 61168-101

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Kybella (NDC 61168-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kythera Biopharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Avoid The Marginal Mandibular Nerve Area (Kybella 01)

An anatomical diagram showing the lower jaw and neck region with a marked treatment area below the chin for KYBELLA injection. The illustration includes shaded zones indicating where injections are allowed and areas to avoid, such as the thyroid notch region.*

FDA Label Image

Figure 2. Sagittal View Of Platysma Area (Kybella 02)

An anatomical illustration showing layers of tissue including post-platysmal fat, platysma muscle, and pre-platysmal fat, likely related to subcutaneous injection areas for KYBELLA (Deoxycholic Acid) injection.*

FDA Label Image

Figure 3. Injection Pattern (Kybella 03)

An instructional diagram showing a human neck front view with the thyroid notch labeled. Shaded areas indicate the treatment area and a specific injection pattern for KYBELLA (Deoxycholic Acid) subcutaneous injection solution.*

FDA Label Image

The Chemical Structure Of Deoxycholic Acid. (Kybella 04)

Chemical structure diagram of Deoxycholic Acid, the active ingredient in KYBELLA injection solution. The diagram shows its molecular configuration with labeled hydroxyl and carboxyl functional groups.*

FDA Label Image

Figure 5. ≥ 2-grade And ≥ 1-grade Composite Clinician And Patient Response (Kybella 05)

Two line graphs titled 'At Least 2-Grade Reduction Composite Response' and 'At Least 1-Grade Reduction Composite Response' depicting response rates of placebo versus KYBELLA over various treatment evaluation time points, shown as percentages of patients responding.*

FDA Label Image

Principal Display Panelkybella™(deoxycholic Acid) Injection 10 mg/ml20 mg/2 mL(10 mg/ml)for Subcutaneous Use Onlyrx Only (Kybella 07)

KYBELLA 20 mg/2 mL solution for injection in a 2 mL single-dose vial. The label includes the product name KYBELLA, the generic name Deoxycholic Acid, and the labeler Kythera Biopharmaceuticals Inc. The vial is clear with a white and orange label and a metal cap with a rubber stopper. The NDC 61168-101 is visible on the label.*

FDA Label Image

Kybella 08

KYBELLA 20 mg/2 mL (10 mg/mL) injection solution label for subcutaneous use by Kythera Biopharmaceuticals Inc., distributed by Allergan USA. The label includes storage instructions, single use vial information, and dosing concentration for the prescription drug containing deoxycholic acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.